Although there are two receptors for IGFs, IGF-1R and IGF-2R, IGF-2R does not transduce a signal and acts to reduce the bioavailability of IGF-2 by sequestering it away from IGF-1R and thus acts as a tumor suppressor [20]. The gene discussed is IGF2; the disease is neoplasm.